Compare KVUE & KB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KVUE | KB |
|---|---|---|
| Founded | 2022 | 2008 |
| Country | United States | South Korea |
| Employees | N/A | N/A |
| Industry | Specialty Chemicals | Commercial Banks |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.1B | 31.3B |
| IPO Year | 2023 | N/A |
| Metric | KVUE | KB |
|---|---|---|
| Price | $18.51 | $113.53 |
| Analyst Decision | Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $19.58 | N/A |
| AVG Volume (30 Days) | ★ 62.2M | 278.1K |
| Earning Date | 02-17-2026 | 02-06-2026 |
| Dividend Yield | ★ 4.44% | 1.78% |
| EPS Growth | ★ 35.31 | 20.12 |
| EPS | 0.75 | ★ 10.59 |
| Revenue | ★ $15,006,000,000.00 | $10,794,642,823.00 |
| Revenue This Year | N/A | $15.59 |
| Revenue Next Year | $2.72 | $3.22 |
| P/E Ratio | $25.01 | ★ $9.90 |
| Revenue Growth | N/A | ★ 3.82 |
| 52 Week Low | $14.02 | $46.38 |
| 52 Week High | $25.17 | $117.24 |
| Indicator | KVUE | KB |
|---|---|---|
| Relative Strength Index (RSI) | 66.60 | 79.67 |
| Support Level | $17.96 | $90.99 |
| Resistance Level | $18.97 | $117.24 |
| Average True Range (ATR) | 0.37 | 2.86 |
| MACD | 0.08 | 1.60 |
| Stochastic Oscillator | 72.57 | 84.78 |
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.
KB Financial Group Inc. is a financial holding company in Korea. The company operations include Kookmin Bank, one of the commercial banks in Korea. The company's subsidiaries collectively engage in a broad range of businesses, including commercial banking, credit cards, asset management, non-life and life insurance, capital markets activities, and international banking and finance. The company's segments include the Banking business, Securities business, Non-life Insurance business, Credit card business, and Life Insurance business. The Group generates the majority of its revenue from the Banking business.